FİLİZ SADİ AYKAN,FATİH ÇÖLKESEN,ŞEVKET ARSLAN

  • FATİH ÇÖLKESEN: NECMETTİN ERBAKAN ÜNİVERSİTESİ
  •  Year : 2022
  •  Vol : 2
  •  Issue : 1
  •  Page : 27-37

ABSTRACT

It is crucial to distinguish bradikinin-mediated angioedema from mast cell-mediated angioedema. Bradykinin mediated angioedema often presents with severe or even life-threatening swelling. Bradykinin-mediated angioedema does not respond to standard treatments used for mast cell-mediated angioedema. Nowadays, the development of new drugs has made it possible to treat bradykinin-mediated angioedema-related attacks and to prevent morbidity and mortality. In this article, the known and unknown aspects of bradykinin-related angioedema, its pathophysiology, diagnosis and differential diagnosis, and treatment modalities are discussed.

Key words: Bradykinin-mediated angioedema, Hereditary angioedema

Cite this Article As : Sadi Aykan F, Çölkesen F, Arslan Ş. Herediter Anjioödem. Mev Med Sci. 2022;2(1):27-37

Conflict of interest : Yok

This article is published under the CC BY-NC 4.0 license.
Mevlana Tıp Bilimleri
2022, Vol2, Issue1
E-ISSN: 2757-976X
Received : , Accepted : , Published Online :